Annual rank1
Poland · Healthcare
Synektik
Provides products, services and IT solutions for surgery, imaging diagnostics, nuclear medicine and healthcare robotics.
FY2022–FY2025
FY2022–FY2025
FY2022–FY2025
current context only
Company profile
Robotics, PET tracers and software for clinical workflows
Synektik is a Polish healthcare-technology group operating across surgical robotics, diagnostic imaging, nuclear medicine and medical IT. It combines its own PET radiopharmaceuticals and software with selected systems from international manufacturers, then supplies the engineering, installation, training, testing and service needed to make those technologies work inside hospitals across Central Europe and the Baltic states.
Robotics and precision medicine
From a lung-biopsy route map to robotic surgery
Synektik distributes Intuitive's da Vinci surgical systems and introduced the Ion robotic platform in Poland for navigating to hard-to-reach lung nodules. Its wider portfolio also covers Symani microsurgery, ZAP-X radiosurgery and MR-guided focused-ultrasound neurosurgery with Exablate Neuro.
- Ion robotic bronchoscopy A 3D airway map, shape-sensing catheter and lung-biopsy workflow
- da Vinci robotic surgery System components, clinical fields and Synektik support
- ▶ VideoWatch: da Vinci procedure Language-neutral surgical footage embedded by Synektik
- Intuitive partnership Exclusive distribution rights and regional development through 2029
- Symani microsurgery Robotic microsurgery and supermicrosurgery for vessels, nerves and lymphatic structures
- ZAP-X and MRgFUS Radiosurgery and focused-ultrasound neurosurgery in Synektik's neurology portfolio
Radiopharmaceuticals
Short-lived PET tracers made at three cyclotron sites
Synektik Pharma manufactures and distributes tracers used in PET diagnostics from Kielce, Warsaw and Mszczonów. The listed portfolio includes products for oncology, cardiology and neurology; its Clinical Trials Center can also synthesise novel tracers on demand and arrange land or air delivery to study sites.
- Radiopharmaceutical portfolio Named PET tracers, indications and three production locations
- Clinical Trials Center Custom synthesis, regulatory support and dose delivery for studies
- Radiopharmacy capabilities Synektik Pharma products, devices and clinical-trial services
Medical software and AI
Move images, results and radiation records through one workflow
ArPACS brings PACS, RIS and image-viewing modules into a radiology environment. Zbadani.pl connects imaging centres, clinicians and patients through DICOM-compatible records and secure result sharing, while SynDose tracks ionising-radiation doses and Qure.ai adds automated image assessment.
- ArPACS Synektik's PACS, RIS and diagnostic-image environment
- Zbadani.pl A browser-based pathway for images, results and consultations
- SynDose Monitoring and reporting ionising-radiation doses
- Qure.ai partnership AI-supported assessment of X-ray, CT and mammography images
Hospital integration and service
A technology sale can begin with construction work
A turnkey project can include room adaptation, imaging or therapy equipment, PACS/RIS deployment, diagnostic workstations and staff training. Synektik also supplies BD Rowa storage-and-dispensing robots and APOTECAchemo systems for automated oncology-drug preparation, then maintains specialised devices and supports customers across Poland, Czechia, Slovakia and the Baltic states.
- Turnkey clinical delivery Equipment, room adaptation, software, workstations and training
- Imaging integration Diagnostic-laboratory planning and authorised equipment supply
- Technical services IT support, medical-equipment maintenance and specialist tests
- Accredited equipment tests Acceptance and specialist measurements for X-ray and nuclear medicine
- Baltic expansion The regional company serving Lithuania, Latvia and Estonia
- Hospital-pharmacy automation BD Rowa storage and APOTECAchemo preparation in a hospital implementation
Official profile sources: Synektik is the world’s leading distributor of da Vinci robotic surgery systems · Record-breaking year and fourth quarter in the Synektik Group · About Synektik Group · System robotyczny do mikrochirurgii Symani w Krakowie
Current 2026 update
What has changed in 2026?
Agreement signed 16 July 2026 · 16 July 2026
Agreement signed 16 July 2026latest official update
4company-specific highlights
+56%2026 stock return · context only
Six-month sales
Net sales revenue reached PLN 441.2 million, up 34.6% from the comparable six-month period.
Orders, backlog and bids
Nine-month purchase orders were about PLN 423 million versus PLN 246 million; at 30 June, backlog was PLN 44.2 million versus PLN 32.8 million and active bids PLN 160.8 million versus PLN 137.0 million.
Cash flow and net debt
Six-month net cash flow was negative PLN 48.1 million versus negative PLN 28.8 million, and the group moved to PLN 20.9 million of net debt from PLN 21.0 million of net cash; a PLN 91.7 million dividend was a major cash-flow factor.
Da Vinci instruments agreement
Synektik signed a 12-month agreement to supply da Vinci surgical instruments, with a maximum net value of PLN 18.64 million.
Official 2026 sources: Management report for Synektik S.A. and the Synektik Group, 1 October 2025 to 31 March 2026 · 11 June 2026 · Operational highlights of the medical devices, IT solutions and services sales segment · 14 July 2026 · Information on the conclusion of a significant sales agreement · 16 July 2026
Annual record
Ranking history
Future editions add rows; they do not rewrite the 2026 record.
| Edition | Measurement period | Rank | Revenue growth | Net-income growth | Stock return |
|---|---|---|---|---|---|
| 2026 | FY2022–FY2025 | 1 | +364% | +1028% | +875% |